Concourse Financial Group Securities’s Kyntra Bio KYNB Stock Holding History

Concourse Financial Group Securities’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	-$2.1K	–	2308
2020 Q3	$2K	Buy	2 +1	+100%	+$1.08K	﹤0.01%	1996
2020 Q2	$2K	Hold	1	–	–	﹤0.01%	1896
2020 Q1	$1K	Hold	1	–	–	﹤0.01%	2030
2019 Q4	$2K	Buy	+1	New	+$1.02K	﹤0.01%	1885
2019 Q3	–	Sell	-1	Closed	-$1.1K	–	1881
2019 Q2	$2K	Sell	1 -1	-50%	-$1.09K	﹤0.01%	1991
2019 Q1	$3K	Buy	+2	New	+$2.71K	﹤0.01%	1916

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Concourse Financial Group Securities's KYNB Position: Q4 2020 in Review

Concourse Financial Group Securities sold out of Kyntra Bio (KYNB) in Q4 2020, closing a stake of 2 shares — an estimated $2.1K sold.

Concourse Financial Group Securities first reported a position in KYNB in Q1 2019 and held it in 6 quarters. The position peaked at $3K in Q1 2019. 207 funds tracked by Wall St. Rank hold KYNB as of Q4 2020.

Concourse Financial Group Securities reported no remaining Kyntra Bio position as of Q4 2020 after selling out during the quarter.
Concourse Financial Group Securities sold 2 Kyntra Bio shares in Q4 2020, an estimated $2.1K.
Concourse Financial Group Securities first reported a position in Kyntra Bio in Q1 2019 and held it in 6 quarters.
Concourse Financial Group Securities's Kyntra Bio position peaked at $3K in Q1 2019.
207 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2020.

Based on Concourse Financial Group Securities's 13F filing for Q4 2020, filed 2 Feb 2021.